Adonis vs Amperos Health
Two Denials & Appeals vendors, side by side. Facts from public sources; judgments are ours.
At a glance
Derived from public facts · a rough scale, not a ranking
| Adonis | Amperos Health | |
|---|---|---|
| Pricing model | Not published · Custom quotes via demo | Not published |
| Speed to go live | API connection to EHR, billing, payer portals | No configuration; working day one |
| Automation model | Autonomous agents · agents plus revenue intelligence alerts | Autonomous agents · AI biller calls and works denials |
| Built for | Mid-size groups, Enterprise systems, Billing companies | Small practices, Mid-size groups, Billing companies |
| Security posture | HIPAA | SOC 2 Type I, HIPAA |
| Company maturity | 4 yrs (est. 2022) | 3 yrs (est. 2023) |
| Financial backing | $95M+ · Series C | $20.2M · Series A |
| Named customers | 5 named | None public |
| Published results | No public numbers | Specific numbers public |
| Documented integrations | 5 listed | None documented |
| Third-party validation | None found | None found |
Bottom line
- Pick Adonis if you want AI agents and revenue analytics layered onto your existing EHR and billing stack without replacing it.
- Pick Amperos if denials and aging A/R are piling up and you want an AI biller chasing claims from day one with no setup project.
Adonis
Revenue intelligence and denial prevention
- Founded
- 2022
- HQ
- New York, NY
- Stage
- Series C
- Raised
- $95M+
What it does
- Real-time revenue intelligence dashboards across the claim lifecycle
- Detects denials, underpayments, and revenue leakage automatically
- AI agents work claims: status checks, appeals, resubmissions
- Prioritized worklists route staff to highest-value tasks
- Alerts on payer behavior changes before revenue impact spreads
- Orchestration layer sits on top of existing billing systems
Where it's strong
- Analytics-first approach surfaces why revenue is leaking, not just that it is, which most billing systems cannot do.
- AI agents now autonomously progress claims, and traction is real: 4x revenue growth in 2025 with Mount Sinai as a flagship customer.
- Works on top of your existing EHR and billing stack rather than replacing it.
What buyers should weigh
- It augments your RCM team rather than replacing it; you still need billers, unlike full-service RCM vendors.
- The company is four years old and scaling fast, so expect some product churn and evolving packaging.
- Value depends on claim volume; small practices may not generate enough data to justify the platform.
Named customers
Mount Sinai Health System · Allied Digestive Health · ApolloMD · Seaview Orthopaedic & Medical Associates · Tend Dental
Integrations
Amperos Health
AI biller that works denials by phone and portal
- Founded
- 2023
- HQ
- New York, NY
- Stage
- Series A
- Raised
- $20.2M
What it does
- Calls payers to check status and dispute denials
- Works payer portals for claim follow-up
- Drafts and submits appeals with medical records
- Submits corrected claims
- Denial analytics and root-cause reporting
Where it's strong
- Automates the actual follow-up work, phone calls included, rather than just flagging denials for staff.
- Real volume behind the claims: over 3,000 clinical locations served and roughly $700M in annual recovered revenue across 500,000-plus claims.
- Pairs AI automation with human billing experts for complex claims instead of forcing everything through the model.
What buyers should weigh
- Founded in 2023, so it is still a young vendor for a function that touches core cash flow.
- Named reference customers are not public; ask for references in your specialty and billing system.
- Best fit is denial follow-up and recovery; it is not a full front-to-back RCM platform.
Compare against the rest of Denials & Appeals
Deciding between these two?
First Pass tracks Denials & Appeals every week: funding, launches, and what changed since this page was written.